Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucía Cortejoso

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Pharmacogenomics|August 23, 2012
Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patientsLucía Cortejoso, Luis A López-Fernández
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|January 22, 2013
Treatment and prophylaxis of catheter-related thromboembolic events in childrenLucía Cortejoso, Silvia Manrique-Rodríguez, Cecilia M Fernández-Llamazares, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|October 18, 2016
Acetazolamide Therapy for Metabolic Alkalosis in Pediatric Intensive Care PatientsCarolina López, Andrés José Alcaraz, Blanca Toledo, et al.
American Journal of Therapeutics|October 19, 2012
Acyclovir and hyponatremia: a case reportLucía Cortejoso, María Gómez-Antúnez, Antonio Muiño-Míguez, et al.
American Journal of Therapeutics|January 25, 2013
Antiangiogenic drugs and cardiogenic shock: a case reportLucía Cortejoso, Javier García-Lledó, Alvaro Giménez-Manzorro, et al.
Pharmacogenomics|June 2, 2016
Cost-effectiveness of screening for DPYD polymorphisms to prevent neutropenia in cancer patients treated with fluoropyrimidinesLucía Cortejoso, Xandra García-González, María I García, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|February 28, 2012
Effectiveness and safety of abatacept in moderate to severe rheumatoid arthritisLucía Cortejoso-Fernández, Maria Rosa Romero-Jiménez, María Sagrario Pernía-López, et al.
Cancer Chemotherapy and Pharmacology|April 2, 2013
Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancerLucía Cortejoso, María I García, Pilar García-Alfonso, et al.
American Journal of Therapeutics|May 17, 2013
Cardiovascular toxicity and sorafenib: a case reportJavier García-Lledó, Lucía Cortejoso, María Tenorio Núñez, et al.
Oncotarget|February 19, 2015
Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancerXandra García-González, Lucía Cortejoso, María I García, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pharmacogenomics|August 23, 2012
Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patientsLucía Cortejoso, Luis A López-Fernández
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|January 22, 2013
Treatment and prophylaxis of catheter-related thromboembolic events in childrenLucía Cortejoso, Silvia Manrique-Rodríguez, Cecilia M Fernández-Llamazares, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|October 18, 2016
Acetazolamide Therapy for Metabolic Alkalosis in Pediatric Intensive Care PatientsCarolina López, Andrés José Alcaraz, Blanca Toledo, et al.
American Journal of Therapeutics|October 19, 2012
Acyclovir and hyponatremia: a case reportLucía Cortejoso, María Gómez-Antúnez, Antonio Muiño-Míguez, et al.
American Journal of Therapeutics|January 25, 2013
Antiangiogenic drugs and cardiogenic shock: a case reportLucía Cortejoso, Javier García-Lledó, Alvaro Giménez-Manzorro, et al.
Pharmacogenomics|June 2, 2016
Cost-effectiveness of screening for DPYD polymorphisms to prevent neutropenia in cancer patients treated with fluoropyrimidinesLucía Cortejoso, Xandra García-González, María I García, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|February 28, 2012
Effectiveness and safety of abatacept in moderate to severe rheumatoid arthritisLucía Cortejoso-Fernández, Maria Rosa Romero-Jiménez, María Sagrario Pernía-López, et al.
Cancer Chemotherapy and Pharmacology|April 2, 2013
Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancerLucía Cortejoso, María I García, Pilar García-Alfonso, et al.
American Journal of Therapeutics|May 17, 2013
Cardiovascular toxicity and sorafenib: a case reportJavier García-Lledó, Lucía Cortejoso, María Tenorio Núñez, et al.
Oncotarget|February 19, 2015
Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancerXandra García-González, Lucía Cortejoso, María I García, et al.
Pageof 2